Cumulative Irritation Test

Completed · Phase 1

Conditions studied: Tinea Pedis

In brief

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Key facts

Study ID

NCT00781664

Run by

Pfizer

People needed

44

Starts

2008-10-01

Expected to finish

2008-11-01

Last updated by the study team

2019-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects must meet all of the following criteria for inclusion in the study.
• Healthy volunteers of either sex, at least 18 years of age or older.
• Females must be of non-childbearing potential (i.e., post-menopausal or surgically sterile [bilateral oophorectomy and/or total hysterectomy]). All females must submit to a urine pregnancy test and have a negative result at Day 1 and at the final study visit.
• Subjects may be of any skin type or race providing their degree of skin pigmentation does not interfere with making readings of skin reactions.
• Willingness to follow the study procedures and complete the study.
• Written informed consent obtained.

You may not qualify if…

• Any skin disease that would in any way confound interpretation of the study results. Atopic dermatitis/eczema, psoriasis will be excluded.
• Chronic asthma will be excluded.
• Pregnant or nursing mothers.
• A history of sensitivity to any component of any of the formulations.
• Use of chronic medications (such as antihistamines, corticosteroids, analgesics and anti-inflammatories) for one week before and during the study.

Where it is running

• The Education and Research Foundation, Inc. — Lynchburg, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.